Clinical Trials Directory

Trials / Unknown

UnknownNCT05813704

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions

A Prospective, Multicenter Clinical Trial in Evaluating the Safety and Efficacy of the Coronary Crossing System in Patients With Coronary Chronic Total Occlusions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Shanghai MicroPort Rhythm MedTech Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective and multicenter clinical investigation aiming to evaluate the safety and effectiveness of coronary crossing system for the treatment of patients with coronary chronic total occlusions.

Detailed description

This study is divided into two phases. The first phase is the pilot study stage, which is a prospective single-group observational test (FIM phase). The second phase is the pivotal study phase, which is a prospective, multi-center, single-group clinical trial (OPC phase). It is carried out in about 20 hospitals in China. 1. Pilot study phase (FIM phase): It is a prospective single-group observational test. It is expected to recruit 10 subjects in a research center in China. 2. Pivotal study phase (OPC phase): It is a prospective, multicenter, single-group clinical trial. 146 subjects are expected to be recruited in 20 research centers in China. 3. All subjects with coronary chronic total occlusions participating in this clinical study must have only a CTO lesion which occluded in length of more than 5 mm and located in a native coronary artery with a diameter of ≥ 2.50 mm (visual inspection). 4. All subjects receive clinical follow-up during hospitalization, 30 days after surgery.

Conditions

Interventions

TypeNameDescription
DEVICECoronary Crossing System of Shanghai MicroPort RhythmThe mechanical vibration generated by the Coronary Crossing System through the piezoelectric effect is amplified and transmitted to the distal end of the guidewire to achieve high-frequency vibration at the tip of the guidewire, and then achieve efficient and safe penetration of the fibrous cap of the CTO.

Timeline

Start date
2023-11-07
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2023-04-14
Last updated
2024-03-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05813704. Inclusion in this directory is not an endorsement.